Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.65668 | 27 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.61361 | 27 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.61685 | 27 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.53983 | 26 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.55297 | 26 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.67322 | 26 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.65137 | 27 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.5874 | 26 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.57441 | 26 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.59934 | 27 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.59909 | 26 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.57877 | 26 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.60494 | 26 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.60416 | 27 |